Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 11;13(6):1434.
doi: 10.3390/biomedicines13061434.

3D Printing in Nasal Reconstruction: Application-Based Evidence on What Works, When, and Why

Affiliations
Review

3D Printing in Nasal Reconstruction: Application-Based Evidence on What Works, When, and Why

Raisa Chowdhury et al. Biomedicines. .

Abstract

Background: Nasal reconstruction requires a balance between aesthetic and functional restoration. Recent advances in three-dimensional (3D) printing have introduced new approaches to this field, enabling precise, patient-specific interventions. This review explores the applications, benefits, and challenges of integrating 3D printing in nasal reconstruction. Methods: A literature search was conducted using PubMed, Scopus, and Web of Science to identify studies on 3D printing in nasal reconstruction. Peer-reviewed articles and clinical trials were analyzed to assess the impact of 3D-printed models, implants, and bioengineered scaffolds. Results: 3D printing facilitates the creation of anatomical models, surgical guides, and implants, enhancing surgical precision and patient outcomes. Techniques such as stereolithography (SLA) and selective laser sintering (SLS) enable high-resolution, biocompatible constructs using materials like polylactic acid, titanium, and hydroxyapatite. Computational fluid dynamics (CFD) tools improve surgical planning by optimizing nasal airflow. Studies show that 3D-printed guides reduce operative time and improve symmetry. Emerging bioprinting techniques integrating autologous cells offer promise for tissue regeneration. Challenges and Future Directions: Challenges include high costs, imaging limitations, regulatory hurdles, and limited vascularization in bioprinted constructs. Future research should focus on integrating bioactive materials, artificial intelligence-assisted design, and regulatory standardization. Conclusions: 3D printing offers specific advantages in nasal reconstruction, improving precision and outcomes in selected cases. Addressing current limitations through technological and regulatory advancements will further its clinical integration, potentially enhancing reconstructive surgery techniques.

Keywords: 3D printing; bioprinting; computational modeling; nasal reconstruction; patient-specific implants; regenerative medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram of study selection process.
Figure 2
Figure 2
Hierarchical framework: translating 3D-printing technology to clinical outcomes in nasal reconstruction.
Figure 3
Figure 3
Decision framework for implementing 3D-printing technologies in nasal reconstruction. The framework guides clinicians through four sequential decision points to determine the appropriate use of 3D printing versus conventional techniques.

Similar articles

References

    1. Yalamanchili H., Sclafani A., Schaefer S., Presti P. The Path of Nasal Reconstruction: From Ancient India to the Present. Facial Plast. Surg. 2008;24:003–010. doi: 10.1055/s-2007-1021457. - DOI - PubMed
    1. Sorta-Bilajac I., Muzur A. The nose between ethics and aesthetics: Sushruta’s legacy. Otolaryngol. Neck Surg. 2007;137:707–710. doi: 10.1016/j.otohns.2007.07.029. - DOI - PubMed
    1. Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. - DOI - PMC - PubMed
    1. Munn Z., Barker T.H., Moola S., Tufanaru C., Stern C., McArthur A., Stephenson M., Aromataris E. Methodological quality of case series studies: An introduction to the JBI critical appraisal tool. JBI Evid. Synth. 2020;18:2127–2133. doi: 10.11124/JBISRIR-D-19-00099. - DOI - PubMed
    1. Higgins J.P., Altman D.G., Gøtzsche P.C., Jüni P., Moher D., Oxman A.D., Savovic J., Schulz K.F., Weeks L., Sterne J.A. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928. - DOI - PMC - PubMed

LinkOut - more resources